dc.creator | Santos García, Diego | es |
dc.creator | Blázquez-Estrada, Marta | es |
dc.creator | Calopa, Matilde | es |
dc.creator | Escamilla-Sevilla, Francisco | es |
dc.creator | Freire, Eric | es |
dc.creator | Mir Rivera, Pablo | es |
dc.creator | Luquín, María-Rosario | es |
dc.date.accessioned | 2021-09-14T15:55:06Z | |
dc.date.available | 2021-09-14T15:55:06Z | |
dc.date.issued | 2021-07-31 | |
dc.identifier.citation | Santos García, D., Blázquez-Estrada, M., Calopa, M., Escamilla-Sevilla, F., Freire, E., Mir Rivera, P. y Luquín, M. (2021). Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project. Brain Sciences, 11 (8), art.n.1027. | |
dc.identifier.issn | 2076-3425 (electrónico) | es |
dc.identifier.uri | https://hdl.handle.net/11441/125752 | |
dc.description.abstract | Abstract: Parkinson’s disease (PD) is a chronic progressive and irreversible disease and the second
most common neurodegenerative disease worldwide. In Spain, it affects around 120.000–150.000
individuals, and its prevalence is estimated to increase in the future. PD has a great impact on
patients’ and caregivers’ lives and also entails a substantial socioeconomic burden. The aim of
the present study was to examine the current situation and the 10-year PD forecast for Spain in
order to optimize and design future management strategies. This study was performed using the
modified Delphi method to try to obtain a consensus among a panel of movement disorders experts. According to the panel, future PD management will improve diagnostic capacity and follow-up, it
will include multidisciplinary teams, and innovative treatments will be developed. The expansion of
new technologies and studies on biomarkers will have an impact on future PD management, leading
to more accurate diagnoses, prognoses, and individualized therapies. However, the socio-economic
impact of the disease will continue to be significant by 2030, especially for patients in advanced
stages. This study highlighted the unmet needs in diagnosis and treatment and how crucial it is to
establish recommendations for future diagnostic and therapeutic management of PD. | es |
dc.format | application/pdf | es |
dc.format.extent | 18 p. | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.relation.ispartof | Brain Sciences, 11 (8), art.n.1027. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Diagnosis | es |
dc.subject | Economic impact | es |
dc.subject | Epidemiology | es |
dc.subject | Management | es |
dc.subject | Mortality | es |
dc.subject | Parkinson’s disease | es |
dc.subject | Quality of life | es |
dc.subject | Spain | es |
dc.subject | Treatment | es |
dc.title | Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Medicina | es |
dc.relation.publisherversion | https://www.mdpi.com/2076-3425/11/8/1027 | es |
dc.identifier.doi | 10.3390/brainsci11081027 | es |
dc.journaltitle | Brain Sciences | es |
dc.publication.volumen | 11 | es |
dc.publication.issue | 8 | es |
dc.publication.initialPage | art.n.1027 | es |